WestCX Launches Engage: Real-Time AI That Speaks, Listens, and Learns Across Every Patient Interaction
WestCX (NASDAQ:APO) launched Engage, an AI-native patient engagement platform that unites Engage, LinguaAI, and Journey Insights into one ecosystem on November 4, 2025. Engage offers streaming speech-to-speech AI for human-like, compliant conversations to automate scheduling, insurance verification, payments, and reminders.
The company says Engage reduces no-shows ~20–35%, supports > 100 languages via LinguaAI, integrates with EHR/CRM, and captures interactions with Journey Insights to measure performance and predict next best actions.
WestCX (NASDAQ:APO) ha lanciato Engage, una piattaforma di coinvolgimento dei pazienti native AI che unisce Engage, LinguaAI e Journey Insights in un unico ecosistema il 4 novembre 2025. Engage offre un'AI di streaming speech-to-speech per conversazioni simili a quelle umane e conformi per automatizzare la programmazione, la verifica dell'assicurazione, i pagamenti e i promemoria.
L'azienda sostiene che Engage riduca i no-show di circa 20–35%, supporti oltre 100 lingue tramite LinguaAI, si integri con EHR/CRM e catturi le interazioni con Journey Insights per misurare la performance e prevedere le prossime azioni migliori.
WestCX (NASDAQ:APO) lanzó Engage, una plataforma nativa de IA para la participación de pacientes que une Engage, LinguaAI y Journey Insights en un único ecosistema el 4 de noviembre de 2025. Engage ofrece IA de voz a voz en streaming para conversaciones humanas y conformes para automatizar la programación, la verificación de seguros, los pagos y los recordatorios.
La empresa afirma que Engage reduce las inasistencias entre ~20–35%, admite más de 100 idiomas mediante LinguaAI, se integra con EHR/CRM y captura las interacciones con Journey Insights para medir el rendimiento y predecir las próximas mejores acciones.
WestCX (NASDAQ:APO)은 2025년 11월 4일 Engage를 출시했습니다. 이는 Engage, LinguaAI, Journey Insights를 하나의 생태계로 묶는 AI 기반 환자 참여 플랫폼입니다. Engage는 인간과 유사하고 규정을 준수하는 대화를 자동화하기 위해 스트리밍 음성-대-음성 AI를 제공하여 일정 관리, 보험 확인, 결제 및 알림을 자동화합니다.
회사 측에 따르면 Engage는 노쇼를 약 20–35% 감소시키고, LinguaAI를 통해 100개 이상의 언어를 지원하며, EHR/CRM과 통합되고 Journey Insights를 통해 상호작용을 수집하여 성과를 측정하고 다음에 취할 최적의 행동을 예측합니다.
WestCX (NASDAQ:APO) a lancé Engage, une plateforme d'engagement des patients native IA qui réunit Engage, LinguaAI et Journey Insights dans un seul écosystème le 4 novembre 2025. Engage propose une IA de type speech-to-speech en streaming pour des conversations humaines et conformes afin d'automatiser la planification, la vérification d'assurance, les paiements et les rappels.
L'entreprise affirme qu'Engage réduit les absences de rendez-vous d'environ 20–35%, prend en charge plus de 100 langues via LinguaAI, s'intègre à EHR/CRM et capture les interactions avec Journey Insights pour mesurer les performances et prédire les prochaines meilleures actions.
WestCX (NASDAQ:APO) hat am 4. November 2025 Engage eingeführt, eine KI-native Plattform für Patientenbindung, die Engage, LinguaAI und Journey Insights in eine einzige Ökosystem vereint. Engage bietet Streaming-Sprach-zu-Sprach-KI für menschliche, konforme Gespräche zur Automatisierung von Terminplanung, Versicherungsüberprüfung, Zahlungen und Erinnerungen.
Das Unternehmen sagt, Engage reduziere No-Shows um rund 20–35%, unterstütze mehr als 100 Sprachen via LinguaAI, integriere sich in EHR/CRM und erfasse Interaktionen mit Journey Insights, um Leistung zu messen und die nächsten besten Maßnahmen vorherzusagen.
WestCX (NASDAQ:APO) أطلقت Engage، منصة تفاعل المرضى المعتمدة على الذكاء الاصطناعي التي توحِّد Engage و LinguaAI و Journey Insights في نظام بيئي واحد في 4 نوفمبر 2025. تقدم Engage ذكاءً اصطناعياً صوتاً إلى صوتاً في البث المباشر لمحادثات تشبه البشر ومتوافقة آمنياً لأتمتة الجدولة والتحقق من التأمين والمدفوعات والتذكيرات.
تقول الشركة إن Engage تقلل حالات عدم الحضور بنحو 20–35%، وتدعم أكثر من 100 لغة عبر LinguaAI، وتتكامل مع EHR/CRM وتلتقط التفاعلات مع Journey Insights لقياس الأداء وتوقع أفضل الإجراءات التالية.
- No-show reduction of roughly 20–35%
- Supports over 100 languages in real time
- Automates appointment scheduling, insurance, payments, reminders
- Integrates with existing EHR and CRM systems
- Captures interactions for analytics via Journey Insights
- None.
Insights
New AI-native platform unifies speech, multilingual support, and analytics for patient engagement; claims measurable operational gains.
WestCX's launch bundles Engage, LinguaAI, and Journey Insights into a single ecosystem that automates common administrative tasks and captures interaction data. The platform emphasizes streaming Speech-to-Speech conversational capabilities, integration with EHR and CRM systems, and compliance with HITRUST, HIPAA, SOC 2, and PCI, which together explain how the product could reduce friction and administrative load.
Key dependencies and risks rest on real-world integration, model performance, and maintained compliance; seamless EHR/CRM connectivity and accurate language handling determine operational value. The claim of reducing no-shows by roughly
Watch for published customer deployment metrics and third-party audits that confirm the
New Engage, LinguaAI, and Journey Insights solutions bring multilingual, measurable, and human-like communication to healthcare organizations
OMAHA, Neb., Nov. 04, 2025 (GLOBE NEWSWIRE) -- WestCX, part of West Technology Group, today announced the launch of Engage, the next generation of its AI-native engagement platform. The launch unites Engage, LinguaAI, and Journey Insights into a single ecosystem that enables healthcare organizations to deliver intelligent, multilingual, and measurable patient experiences. Together, these innovations help improve satisfaction, reduce missed appointments, and make care more accessible and equitable for all patients.
Engage: Streaming Speech-to-Speech AI that Transforms Patient Communication
Engage introduces a breakthrough in streaming Speech-to-Speech AI, setting a new standard for natural, intelligent, and compliant patient communication. Building on Mosaicx’ proven deployments, Engage now extends across the full WestCX portfolio, including its Televox brand. Engage empowers healthcare systems, payers, and pharmaceutical organizations to hold human-like conversations that understand, act, and learn in real time.
“Engage goes beyond static automation, creating personalized patient experiences and reducing friction in the care journey,” said Alpa Shah, Global Vice President – CX Practice at Frost & Sullivan. “The deep integration of generative AI and intelligent automation throughout the platform reinforces WestCX as a true innovator in AI-powered patient engagement.”
The platform combines conversational, generative, and agentic AI to automate core functions, such as appointment scheduling, insurance verification, payments and medication reminders, all within a single exchange.
Engage delivers measurable results:
- Accelerates ROI by automating high-volume administrative tasks and improving patient throughput.
- Reduces patient no-shows by roughly 20
-35% , empowering organizations to recapture revenue and focus staff on critical care. - Integrates seamlessly with existing EHR and CRM systems, enabling personalized care journeys that adapt in real time.
- Ensures every conversation is secure and HITRUST, HIPAA, SOC 2, and PCI-compliant.
LinguaAI: Multilingual Engagement at Scale
Complimenting Engage, LinguaAI redefines accessibility and inclusion. Supporting over 100 languages in real time, LinguaAI delivers context-aware conversations that reflect empathy and understanding, ensuring patients receive high-quality care, regardless of language or background.
For health systems serving Limited English Proficiency (LEP) populations, this means inclusive communication that scales without compromising security or compliance.
Journey Insights: Turning Engagement into Intelligence
Journey Insights converts every patient interaction into actionable intelligence. By capturing and analyzing calls, messages, and digital interactions across channels, it becomes a source of truth that reveals friction points and benchmarks performance. The solution also predicts next best actions that drive higher satisfaction, containment, and care outcomes.
“Journey Insights goes a step further by turning everyday interactions into opportunities for improvement,” said Sam Meckey, President of WestCX. “With Engage, LinguaAI, and Journey Insights, we are raising the bar for communication in regulated industries. These solutions make every interaction more natural, inclusive, and data-driven, improving outcomes while reducing operational cost.”
Redefining the Standard for Patient Engagement
Together, Engage, LinguaAI, and Journey Insights form an AI-native engagement ecosystem that listens, learns, and adapts. This approach transforms patient communication from a transactional process into a continuous relationship that strengthens satisfaction, improves adherence, and delivers measurable financial impact.
The launch marks the next phase in WestCX’s mission to connect the entire patient journey, uniting the capabilities of Televox and Mosaicx under one AI-powered platform purpose-built for healthcare, life sciences, and other highly regulated industries.
See Engage in Action
To see Engage in action and learn more about WestCX’s enterprise engagement solutions, visit televox.com.
About WestCX
WestCX, part of West Technology Group, LLC, is a cloud-based technology partner delivering AI-powered omnichannel engagement solutions. The WestCX brand includes Mosaicx and Televox, trusted names that automate interactions and improve efficiency, satisfaction, and outcomes across patient and customer experiences. With more than 30 years of expertise in enterprise CX and healthcare communication, WestCX is transforming how organizations connect, engage, and serve.
West Technology Group is controlled by affiliates of certain funds managed by Apollo Global Management, Inc. (NYSE: APO).
Media Contact
Lucy Meneghello
Communiqué PR
TelevoxPR@communiquepr.com
206-282-4923 ext. 129